Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis - Influence of concomitant human immunodeficiency virus infection

被引:31
作者
Marra, CM
Longstreth, WT
Maxwell, CL
Lukehart, SA
机构
[1] UNIV WASHINGTON,SCH MED,DEPT MED,DIV NEUROL,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH MED,DEPT MED,DIV INFECT DIS,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SEATTLE,WA 98195
[4] JAMES BOWMAN ASSOCIATES,SEATTLE,WA
关键词
D O I
10.1097/00007435-199605000-00005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: Little is known about resolution of serum and cerebrospinal fluid abnormalities after neurosyphilis treatment, especially in patients infected with human immunodeficiency virus (HIV). Goal: To examine the time course of resolution of these abnormalities. Study Design: Case series of 22 patients with neurosyphilis (13 infected with HIV) with reactive cerebrospinal fluid Venereal Disease Research Laboratory test who underwent at least one lumbar puncture after treatment. Results: Resolution of all serum and cerebrospinal fluid measures was slower in patients infected with HIV, Serum and cerebrospinal fluid abnormalities resolved in most patients not infected with HIV by 30 weeks, and all met Centers for Disease Control and Prevention criteria for cure. One patient infected with HIV failed therapy by Centers for Disease Control and Prevention criteria, and three others had persistent pleocytosis. Conclusions: HIV-infected patients with neurosyphilis have slower resolution of serum and cerebrospinal fluid abnormalities after therapy, This observation may suggest impaired clearance of Treponema pallidum from the central nervous system.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 26 条
[1]   CEREBROSPINAL-FLUID ABNORMALITIES IN PATIENTS WITHOUT AIDS WHO ARE SEROPOSITIVE FOR THE HUMAN IMMUNODEFICIENCY VIRUS [J].
APPLEMAN, ME ;
MARSHALL, DW ;
BREY, RL ;
HOUK, RW ;
BEATTY, DC ;
WINN, RE ;
MELCHER, GP ;
WISE, MG ;
SUMAYA, CV ;
BOSWELL, RN .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (01) :193-199
[2]   SEROLOGICAL RESPONSE TO SYPHILIS TREATMENT - A NEW ANALYSIS OF OLD DATA [J].
BROWN, ST ;
ZAIDI, A ;
LARSEN, SA ;
REYNOLDS, GH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (09) :1296-1299
[3]   SENSITIVE DETECTION OF TREPONEMA-PALLIDUM BY USING THE POLYMERASE CHAIN-REACTION [J].
BURSTAIN, JM ;
GRIMPREL, E ;
LUKEHART, SA ;
NORGARD, MV ;
RADOLF, JD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (01) :62-69
[4]   RESPONSE OF LATENT SYPHILIS OR NEUROSYPHILIS TO CEFTRIAXONE THERAPY IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DOWELL, ME ;
ROSS, PG ;
MUSHER, DM ;
CATE, TR ;
BAUGHN, RE .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (05) :481-488
[5]   NEUROSYPHILIS IN AIDS PATIENTS - INITIAL CSF VDRL MAY BE NEGATIVE [J].
FERARU, ER ;
ARONOW, HA ;
LIPTON, RB .
NEUROLOGY, 1990, 40 (03) :541-543
[6]   THE RESPONSE OF SYMPTOMATIC NEUROSYPHILIS TO HIGH-DOSE INTRAVENOUS PENICILLIN-G IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
GORDON, SM ;
EATON, ME ;
GEORGE, R ;
LARSEN, S ;
LUKEHART, SA ;
KUYPERS, J ;
MARRA, CM ;
THOMPSON, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1469-1473
[7]   EFFECTS OF HIV-INFECTION ON THE SEROLOGIC MANIFESTATIONS AND RESPONSE TO TREATMENT OF SYPHILIS IN INTRAVENOUS-DRUG-USERS [J].
GOUREVITCH, MN ;
SELWYN, PA ;
DAVENNY, K ;
BUONO, D ;
SCHOENBAUM, EE ;
KLEIN, RS ;
FRIEDLAND, GH .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (05) :350-355
[8]   ALTERED CLINICAL PRESENTATION OF EARLY SYPHILIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
HUTCHINSON, CM ;
HOOK, EW ;
SHEPHERD, M ;
VERLEY, J ;
ROMPALO, AM .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (02) :94-99
[9]   NEUROSYPHILIS - A COMPARATIVE-STUDY OF THE EFFECTS OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
KATZ, DA ;
BERGER, JR ;
DUNCAN, RC .
ARCHIVES OF NEUROLOGY, 1993, 50 (03) :243-249
[10]  
LARSEN S, 1990, MANUAL TESTS SYPHILI